Cargando…
Effects of Yangxinshi tablet on exercise tolerance in patients with coronary heart disease: A protocol of randomized, double-blind, placebo-controlled, and multi-center trial
BACKGROUND: Exercise intolerance is very common in patients with coronary heart disease (CHD). Although some researches confirming the validation of traditional Chinese medicine (TCM) on CHD treatment, the effect of TCM on improving the exercise tolerance of patients with CHD remains unclear so far....
Autores principales: | Zhang, Sisi, Liang, Congying, Yang, Yang, Zhao, Zhijia, Li, Jiaojiao, Meng, Xiaoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402915/ https://www.ncbi.nlm.nih.gov/pubmed/32756176 http://dx.doi.org/10.1097/MD.0000000000021485 |
Ejemplares similares
-
A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Taoren Honghua Jian granule in patients with stable coronary artery disease
por: Wang, Yiru, et al.
Publicado: (2019) -
Efficacy of erzhu jiedu recipe on hepatitis B cirrhosis with hyperalphafetoproteinemia: A randomized, double-blind, placebo-controlled clinical trial
por: Chen, Tian-Yang, et al.
Publicado: (2021) -
A randomized double-blind placebo-controlled multicenter trial of Bushen Yisui and Ziyin Jiangzhuo formula for constipation in Parkinson disease
por: Jin, Zhaohui, et al.
Publicado: (2020) -
Effects and safety of intranasal phototherapy for allergic rhinitis: Study protocol for a single-center, randomized, double-blind, parallel, placebo-controlled, investigator-initiated, pilot study
por: Kang, Jeongin, et al.
Publicado: (2020) -
A multi-center, randomized, double-blind, placebo-parallel controlled trial for the efficacy and safety of shenfuqiangxin pills in the treatment of chronic heart failure (Heart-Kidney yang deficiency syndrome)
por: Guo, Lijun, et al.
Publicado: (2020)